DOW
24
4
GRMN
40
4
ALL
64
7
VMC
68
3
AMG
52
8
EXR
50
6
MMM
44
14
CMA
45
2
IFF
42
3
LOW
49
4
DIS
66
5
GOOGL
40
6
NEM
55
-2
WMT
67
4
CNP
67
7
DHR
46
3
SHW
48
3
AEE
78
9
VLO
36
3
XYL
33
6
DOW
24
4
GRMN
40
4
ALL
64
7
VMC
68
3
AMG
52
8
EXR
50
6
MMM
44
14
CMA
45
2
IFF
42
3
LOW
49
4
DIS
66
5
GOOGL
40
6
NEM
55
-2
WMT
67
4
CNP
67
7
DHR
46
3
SHW
48
3
AEE
78
9
VLO
36
3
XYL
33
6
Financhill
Back

Dynavax Technologies 10K Form

Sell
24

DVAX
Dynavax Technologies

Last Price:
$10.73
Seasonality Move:
13.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-08 10Q DVAX/Dynavax Technologies Quarterly
2023-11-02 10Q DVAX/Dynavax Technologies Quarterly
2023-08-03 10Q DVAX/Dynavax Technologies Quarterly
2023-05-02 10Q DVAX/Dynavax Technologies Quarterly
2022-11-03 10Q DVAX/Dynavax Technologies Quarterly
2022-08-04 10Q DVAX/Dynavax Technologies Quarterly

Receive DVAX News And Ratings

See the #1 stock for the next 7 days that we like better than DVAX

DVAX Financial Statistics

Sales & Book Value

Annual Sales: $277.2M
Cash Flow: $49.5M
Price / Cash Flow: 25.48
Annual Sales: $4.76
Price / Book: 2.23

Profitability

EPS (TTM): 0.18000
Net Income (TTM): $27.3M
Gross Margin: $227.8M
Return on Equity: 4.32%
Return on Assets: 2.71%

Dynavax Technologies Earnings Forecast

Key Dynavax Technologies Financial Ratios

  • The Gross Profit Margin over the past 20 years for DVAX is 82.17%.
  • The Selling, General & Administrative Expenses for DVAX have been equal to 61.45% of Gross Profit Margin.
  • The Research & Development expenses have been 22.20% of Revenue.
  • The Interest Expense is 24.88% of Operating Income.
  • The Net Earning history of DVAX is 9.85% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 18 years.

Dynavax Technologies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: DVAX
CUSIP: 268158
Website: dynavax.com

Debt

Debt-to-Equity Ratio: 0.38
Current Ratio: 10.8
Quick Ratio: 9.67

Price-to-Earnings

Trailing P/E Ratio: 53.6
Forward P/E Ratio: 20.1

DVAX Technical Analysis vs Fundamental Analysis

Sell
24
Dynavax Technologies (DVAX) is a Sell

Is Dynavax Technologies a Buy or a Sell?